Clinical trial
A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention…
NCT00172042 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00172042 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) |
| Official title | A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Small-Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Zoledronic acid 4 mg |
| Enrollment | 437 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | May 4, 2015 |
| Countries | Belgium, China, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Portugal, South Korea, Spain and 3 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: